Healthcare Equipment and Supplies
Company Overview of OrthoAccel Technologies, Inc.
OrthoAccel Technologies, Inc., a medical device company, develops, manufactures, and markets products for dental care and orthodontic treatment. It offers AcceleDent Aura, a hands-free device that accelerates orthodontic tooth movement for orthodontic treatment. The company offers its products through orthodontic practices in the United States and internationally. OrthoAccel Technologies, Inc. was incorporated in 2006 and is based in Bellaire, Texas.
6575 West Loop South
Bellaire, TX 77401
Founded in 2006
Key Executives for OrthoAccel Technologies, Inc.
Chief Executive Officer, President and Director
Chief Financial Officer and Vice President of Finance & Administration
Chief Innovation Officer and Vice President of Marketing
Managing Director for Europe, Middle East and Africa (EMEA)
Compensation as of Fiscal Year 2016.
OrthoAccel Technologies, Inc. Key Developments
OrthoAccel®Technologies, Inc. Names Mark Steele as Senior Vice President of North America Sales
Oct 12 16
OrthoAccel®Technologies, Inc. announced that Mark Steele has joined the company as senior vice president of North America sales. Most recently Steele served as executive vice president of sales, marketing and customer service for MSD. At MSD, Steele oversaw inside and outside sales teams. Prior to MSD, Steele had an 18-year career at PSS World Medical, Inc., where he was named president of the company's extended care business, Gulf South Medical Supply, Inc., after rising through the ranks of sales representative, regional vice president of sales and vice president of marketing for the company's physician business.
OrthoAccel Technologies, Inc. Presents at JMP Securities 2016 Life Sciences Conference, Jun-21-2016 01:00 PM
May 14 16
OrthoAccel Technologies, Inc. Presents at JMP Securities 2016 Life Sciences Conference, Jun-21-2016 01:00 PM. Venue: The St. Regis New York, 2 East 55th Street, New York, NY 10022, United States.
OrthoAccel Announces Publication of Randomized Controlled Trial Results
Sep 9 15
OrthoAccel announced publication of randomized controlled trial results. The trial, which was conducted at the University of Texas Health Science Center at San Antonio, assessed 45 orthodontic patients who were randomized into two groups the AcceleDent group and a control group. Patients in the AcceleDent group were given the hands-free device that employs patented SoftPulse Technology® and were instructed to bite down on the device's mouthpiece for 20 minutes a day. AcceleDent delivered the safe, gentle vibrations needed to stimulate tooth movement at the cellular level. Results indicated that the rate of movement was significantly higher for the AcceleDent group versus the control group. An FDA-cleared, Class II medical device, AcceleDent speeds up orthodontic treatment by as much as 50% and orthodontists as well as patients report that AcceleDent relieves the discomfort often associated with orthodontics. AcceleDent is currently available in more than 2,700 orthodontic locations in the U.S. and Canada. The results of this RCT have been applauded by distinguished clinical researchers and scientists.
Similar Private Companies By Industry
Recent Private Companies Transactions
February 24, 2016